Thapsigargin-From Traditional Medicine to Anticancer Drug

被引:88
作者
Jaskulska, Agata [1 ,2 ]
Janecka, Anna Ewa [2 ]
Gach-Janczak, Katarzyna [2 ]
机构
[1] Lodz Univ Technol, Inst Organ Chem, Zeromskiego 116, PL-90924 Lodz, Poland
[2] Med Univ Lodz, Dept Biomol Chem, Mazowiecka 6-8, PL-92215 Lodz, Poland
关键词
thapsigargin; cytotoxin; anticancer activity; sarcoplasmic/endoplasmic reticulum Ca2+ ATPase; unfold protein response; apoptosis; prodrug; prostate-specific antigen; prostate-specific membrane antigen; mipsagargin; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN-RESPONSE; PROSTATE-SPECIFIC ANTIGEN; ER CA2+ DEPLETION; CELL-DEATH; THERAPEUTIC TARGET; INDUCED APOPTOSIS; NATURAL-PRODUCTS; TROJAN HORSE; SERCA PUMP;
D O I
10.3390/ijms22010004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A sesquiterpene lactone, thapsigargin, is a phytochemical found in the roots and fruits of Mediterranean plants from Thapsia L. species that have been used for centuries in folk medicine to treat rheumatic pain, lung diseases, and female infertility. More recently thapsigargin was found to be a potent cytotoxin that induces apoptosis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pump, which is necessary for cellular viability. This biological activity encouraged studies on the use of thapsigargin as a novel antineoplastic agent, which were, however, hampered due to high toxicity of this compound to normal cells. In this review, we summarized the recent knowledge on the biological activity and molecular mechanisms of thapsigargin action and advances in the synthesis of less-toxic thapsigargin derivatives that are being developed as novel anticancer drugs.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 68 条
[31]   A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer [J].
Levy, Oren ;
Brennen, W. Nathaniel ;
Han, Edward ;
Rosen, David Marc ;
Musabeyezu, Juliet ;
Safaee, Helia ;
Ranganath, Sudhir ;
Ngai, Jessica ;
Heinelt, Martina ;
Milton, Yuka ;
Wang, Hao ;
Bhagchandani, Sachin H. ;
Joshi, Nitin ;
Bhowmick, Neil ;
Denmeade, Samuel R. ;
Isaacs, John T. ;
Karp, Jeffrey M. .
BIOMATERIALS, 2016, 91 :140-150
[32]   Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components [J].
Lindner, Paula ;
Christensen, Soren Brogger ;
Nissen, Poul ;
Moller, Jesper Vuust ;
Engedal, Nikolai .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[33]   Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis [J].
Lu, Min ;
Lawrence, David A. ;
Marsters, Scot ;
Acosta-Alvear, Diego ;
Kimmig, Philipp ;
Mendez, Aaron S. ;
Paton, Adrienne W. ;
Paton, James C. ;
Walter, Peter ;
Ashkenazi, Avi .
SCIENCE, 2014, 345 (6192) :98-101
[34]  
LYTTON J, 1991, J BIOL CHEM, V266, P17067
[35]   Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation [J].
Ma, Zhiqiang ;
Fan, Chongxi ;
Yang, Yang ;
Di, Shouyin ;
Hu, Wei ;
Li, Tian ;
Zhu, Yifang ;
Han, Jing ;
Xin, Zhenlong ;
Wu, Guiling ;
Zhao, Jing ;
Li, Xiaofei ;
Yan, Xiaolong .
SCIENTIFIC REPORTS, 2016, 6
[36]   Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours [J].
Mahalingam, D. ;
Wilding, G. ;
Denmeade, S. ;
Sarantopoulas, J. ;
Cosgrove, D. ;
Cetnar, J. ;
Azad, N. ;
Bruce, J. ;
Kurman, M. ;
Allgood, V. E. ;
Carducci, M. .
BRITISH JOURNAL OF CANCER, 2016, 114 (09) :986-994
[37]   A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma [J].
Mahalingam, Devalingam ;
Peguero, Julio ;
Cen, Putao ;
Arora, Sukeshi P. ;
Sarantopoulos, John ;
Rowe, Julie ;
Allgood, Victoria ;
Tubb, Benjamin ;
Campos, Luis .
CANCERS, 2019, 11 (06)
[38]   Improved in vitro rooting and hyperhydricity in regenerating tissues of Thapsia garganica L. [J].
Makunga, Nokwanda P. ;
Jager, Anna K. ;
van Staden, Johannes .
PLANT CELL TISSUE AND ORGAN CULTURE, 2006, 86 (01) :77-86
[39]   A diversity of SERCA Ca2+ pump inhibitors [J].
Michelangeli, Francesco ;
East, J. Malcolm .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 :789-797
[40]   A role for caspase-8 and TRAIL-R2/DR5 in ER-stress-induced apoptosis [J].
Munoz-Pinedo, Cristina ;
Lopez-Rivas, Abelardo .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :226-226